1. Home
  2. ASPS vs CLDI Comparison

ASPS vs CLDI Comparison

Compare ASPS & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASPS
  • CLDI
  • Stock Information
  • Founded
  • ASPS 1999
  • CLDI 2014
  • Country
  • ASPS Luxembourg
  • CLDI United States
  • Employees
  • ASPS N/A
  • CLDI N/A
  • Industry
  • ASPS Other Consumer Services
  • CLDI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ASPS Consumer Discretionary
  • CLDI Health Care
  • Exchange
  • ASPS Nasdaq
  • CLDI Nasdaq
  • Market Cap
  • ASPS 19.8M
  • CLDI 18.1M
  • IPO Year
  • ASPS N/A
  • CLDI N/A
  • Fundamental
  • Price
  • ASPS $0.62
  • CLDI $1.47
  • Analyst Decision
  • ASPS
  • CLDI Strong Buy
  • Analyst Count
  • ASPS 0
  • CLDI 3
  • Target Price
  • ASPS N/A
  • CLDI $16.67
  • AVG Volume (30 Days)
  • ASPS 188.9K
  • CLDI 1.2M
  • Earning Date
  • ASPS 10-24-2024
  • CLDI 11-12-2024
  • Dividend Yield
  • ASPS N/A
  • CLDI N/A
  • EPS Growth
  • ASPS N/A
  • CLDI N/A
  • EPS
  • ASPS N/A
  • CLDI N/A
  • Revenue
  • ASPS $153,278,000.00
  • CLDI N/A
  • Revenue This Year
  • ASPS $15.33
  • CLDI N/A
  • Revenue Next Year
  • ASPS $32.37
  • CLDI N/A
  • P/E Ratio
  • ASPS N/A
  • CLDI N/A
  • Revenue Growth
  • ASPS 5.19
  • CLDI N/A
  • 52 Week Low
  • ASPS $0.62
  • CLDI $0.73
  • 52 Week High
  • ASPS $3.71
  • CLDI $18.50
  • Technical
  • Relative Strength Index (RSI)
  • ASPS 30.70
  • CLDI 37.87
  • Support Level
  • ASPS $0.71
  • CLDI $1.60
  • Resistance Level
  • ASPS $0.86
  • CLDI $2.17
  • Average True Range (ATR)
  • ASPS 0.08
  • CLDI 0.20
  • MACD
  • ASPS -0.00
  • CLDI -0.08
  • Stochastic Oscillator
  • ASPS 1.14
  • CLDI 5.37

About ASPS Altisource Portfolio Solutions S.A.

Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments namely Servicer and Real Estate and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource primarily serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of revenue flowing from field services and mortgage and real estate solutions.

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.

Share on Social Networks: